Main description:

The meaning of Clinical Trials for humans has recently changed significantly,
"evolved", so to speak. In today's environment, where ethical validity is much more
strictly controlled, this meaning is far beyond "human drug testing" and much closer
to the "therapeutic goal". The number of clinical trials in western countries that have
perceived this change has increased rapidly and continues to increase. Although
the number of clinical studies in the MENA region is increasing day by day, it is still
far from its potential. Among the reasons for this are legal, technological, ethical,
epidemiological, educational and economic factors. This book presents both the
difficulties encountered in conducting clinical trials in MENA and suggestions for
solving these difficulties.

Contents:

Fatih OEzdener : General Picture of Clinical Research at MENA - Hamdi Akan : Clinical Trial Designs of the Future - Getting Ready at MENA - Nihan Burul Bozkurt, Goekhan OEzkan : The Role of Regulatory Authorities and TITCK - Irfan Cicin, Ali Goekyer : Role of Investigator - Peri Aytac, Aydin Erenmemisoglu : Early Phase Clinical Trials - Importance of Entry to MENA - OEzgur Kasapcopur, Mehmet Yildiz, Fatih OEzdener : Ethical Considerations (Clinical Research in Pediatric and Sensitive Populations) - Bilge Aydin Temiz : The Requirement and Importance of Legal Regulations in Drug Clinical Trials - Mutlu Hayran, Deniz Yuce : Importance of Epidemiological Data - Baris Erdogan, Le Vin Chin : Clinical Research and Healthcare Digitalization in the Middle East and Turkey - Fatih Ozdener : Sponsoring Clinical Trials at MENA - Need for New Pharmacoeconomic Models - Fatih OEzdener, Alihan Sursal, Zulfiye Gul : Good Clinical Practice Training from the Perspective of Raising Clinical Trial Awareness .